Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Abscopal Effects

  • Gabriele Multhoff
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7217-1



Abscopal effects describe nontargeted, radiotherapy (RT)-induced tumor regression in lesions or tumor or metastatic regions distant from the irradiated site.


More than 50 % of patients with solid tumors are treated with radiotherapy either alone or in combination with chemotherapy. Apart from direct cytotoxic effects of radiation therapy which are predominantly caused by the deposition of low and high LET (Radiosensitization) energy to the nucleus and DNA (DNA Damage; DNA Damage Response; DNA Damage-Induced Apoptosis; Repair of DNA), non-(DNA)-targeting radiation effects that result in tumor regression in lesions distant from the irradiated tumor have been described. These so-called abscopal effects, firstly described by Mole in 1953 (Whole body...


Renal Cell Carcinoma Retinoic Acid Bystander Effect Antitumor Immune Response Immunogenic Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L et al (2004) Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Radiat Oncol Biol 58:862–870. doi:10.1016/j.ijrobp.2003.09.012CrossRefGoogle Scholar
  2. Postow MA, Callahan MK, Barker CA, Yamada Y, Yuan J, Kitano S, Mu Z, Raslan T, Adamow M, Ritter E, Sedrak C, Jungbluth AA, Chua R, Yang AS, Roman RA, Rosner S, Benson B, Allison JP, Lesokhin AM, Gnjatic S, Wolchok JD (2012) Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366:925–931. doi:10.1056/NEJMoa1112824PubMedCentralCrossRefPubMedGoogle Scholar
  3. Rödel F, Frey B, Multhoff G, Gaipl US (2013) Contribution of the immune system to bystander and non-targeted effects of ionizing radiation. Cancer Lett. doi:10.1016/j.canlet.2013.09.015PubMedGoogle Scholar
  4. Tang C, Wang X, Soh H, Cortez MA, Krishnan S, Massarelli E et al (2015) Combining radiation and immunotherapy: a new systematic therapy for solid tumors. Cancer Immunol Res 2:831–837CrossRefGoogle Scholar
  5. Vatner RE, Cooper BT, Vanpouille-Box C, Demaria S, Formenti SC (2014) Combinations of immunotherapy and radiation in cancer therapy. Front Oncol 4:325. doi:10.3389/fonc2014.00325PubMedCentralCrossRefPubMedGoogle Scholar
  6. Wolchok JD, Hoos A, O’Day S, Weber JS, Hamid O, Lebbe C et al (2009) Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin Cancer Res 15:7412–7420. doi:10.1158/1078-432.CCR-09-1624CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Klinikum rechts der Isar, Department Radiation Oncology, TU München and CCG – “Innate Immunity in Tumor Biology”Helmholtz Zentrum MünchenMunichGermany